Skip to main content
HCPCS J3301 · Level II · Part B drug

HCPCS J3301: Injection, triamcinolone acetonide, not otherwise specified, 10 mg

Reviewed by QuickIntell RCM Editorial Team · Last reviewed

Data effective
Data currency: ASP payment limits October 2026 (effective October 1, 2026); MUE and NCCI edits 2026 Q4 (effective October 1, 2026); OPPS Addendum B July 2026 (effective July 1, 2026). Next CMS release: January 1, 2027 (ASP, MUE, NCCI and OPPS quarterly updates).

Key facts for J3301

Billing unit
10 MG
Triamcinolone acet inj nos
ASP payment limit
$0.787
October 2026; -21.0% vs July 2026
Practitioner MUE
16
MAI 3
OPPS status
SI N
NCCI exposure
no PTP pairs
Coverage articles
1
3 states

TL;DR

HCPCS J3301 is the Level II code for Injection, triamcinolone acetonide, not otherwise specified, 10 mg, billed per 10 MG. The Medicare Part B ASP payment limit for October 2026 is $0.787 per billing unit, down 21.0% from July 2026. The practitioner MUE allows up to 16 units per date of service (MAI 3). Under OPPS it carries status indicator N. The 10 mg billing unit means doses are reported in multiples of ten milligrams, with any remainder rounded per contractor policy; mismatched units against the NDC quantity trigger MUE and NDC-unit edits. The ASP crosswalk maps 41 NDCs to it, sold as Kenalog-80, Triamcinolone Acetonide, Kenalog-40 by E.R. Squibb & Sons, L.L.C., Hikma Pharmaceuticals USA Inc., Teva Parenteral Medicines, Inc.. 1 Medicare coverage article lists the code across 3 states, including .

Medicare Part B payment limit (ASP)

CMS sets the Part B payment limit for J3301 at $0.787 per 10 MG for October 2026, derived from manufacturer average sales price plus 6%, compared with $0.996 in July 2026. Beneficiary coinsurance is 20%.

ASP payment limits for J3301
QuarterPayment limitPerCoinsurance
October 2026$0.78710 MG20%
July 2026$0.99610 MG—
Source: CMS Medicare Part B Drug Payment Limit File. Commercial and Medicaid payers set their own rates.

NDC to HCPCS billing-unit conversion

The October 2026 ASP crosswalk maps 41 NDCs from 10 labelers to J3301. Report the NDC in the claim's drug segment and bill the number of J3301 units that equals the quantity administered divided by 10 MG; the last column gives units per full package.

NDCs that crosswalk to J3301
NDCDrug nameLabelerPackage sizeBilling units / package
00003-0293-05Kenalog-80E.R. Squibb & Sons, L.L.C.1 × 14
00003-0293-20Kenalog-80E.R. Squibb & Sons, L.L.C.5 × 120
00003-0293-28Kenalog-80E.R. Squibb & Sons, L.L.C.10 × 140
00003-0315-05Kenalog-80E.R. Squibb & Sons, L.L.C.1 × 18
00003-0315-20Kenalog-80E.R. Squibb & Sons, L.L.C.5 × 140
00003-0494-20Kenalog-80E.R. Squibb & Sons, L.L.C.5 × 15
00143-9387-25Triamcinolone AcetonideHikma Pharmaceuticals USA Inc.1 × 25100
00703-0241-01Triamcinolone AcetonideTeva Parenteral Medicines, Inc.1 × 14
00703-0243-01Triamcinolone AcetonideTeva Parenteral Medicines, Inc.5 × 120
00703-0245-01Triamcinolone AcetonideTeva Parenteral Medicines, Inc.10 × 140
16714-0130-25Triamcinolone AcetonideNorthstar RxLLC1 × 25100
16714-0140-01Triamcinolone AcetonideNorthstar RxLLC5 × 120
16714-0150-01Triamcinolone AcetonideNorthstar RxLLC10 × 140
43598-0676-11Triamcinolone AcetonideDr. Reddy's Laboratories Inc.5 × 15
43598-0694-11Triamcinolone AcetonideDr. Reddy's Laboratories Inc.5 × 120
50090-0256-00Kenalog-40A-S Medication Solutions5 × 120
50090-0295-01Kenalog-40A-S Medication Solutions5 × 15
50090-0819-00Kenalog-40A-S Medication Solutions10 × 140
50090-2360-00Kenalog-40A-S Medication Solutions1 × 14
55150-0384-01Triamcinolone AcetonideEugia US LLC5 × 120
55150-0385-01Triamcinolone AcetonideEugia US LLC10 × 140
67457-0621-02Triamcinolone AcetonideMylan Institutional LLC1 × 14
67457-0621-99Triamcinolone AcetonideMylan Institutional LLC1 × 25100
67457-0622-05Triamcinolone AcetonideMylan Institutional LLC5 × 120
67457-0622-99Triamcinolone AcetonideMylan Institutional LLC5 × 25500
67457-0623-10Triamcinolone AcetonideMylan Institutional LLC10 × 140
67457-0623-99Triamcinolone AcetonideMylan Institutional LLC10 × 251000
70121-1049-02Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 14
70121-1049-05Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 25100
70121-1168-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC5 × 120
70121-1169-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC10 × 140
70121-1651-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 14
70121-1651-05Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 25100
70121-1652-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC5 × 120
70121-1653-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC10 × 140
70121-1654-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC5 × 120
70121-1655-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC10 × 140
70121-1657-01Triamcinolone AcetonideAmneal Pharmaceuticals, LLC1 × 14
81298-5781-05Triamcinolone AcetonideLong Grove Pharmaceuticals, LLC1 × 25100
81298-5783-03Triamcinolone AcetonideLong Grove Pharmaceuticals, LLC10 × 140
81298-5785-03Triamcinolone AcetonideLong Grove Pharmaceuticals, LLC5 × 120

Medically Unlikely Edits (MUE)

CMS publishes 3 MUE values for J3301. For practitioners the limit is 16 units per date of service with adjudication indicator 3, a date-of-service clinical edit: units above the limit deny but can be paid on appeal with documentation that the quantity was medically reasonable.

MUE values for J3301 by setting
SettingMUE (units/DOS)MAICMS rationale
Practitioner services163 Date of Service Edit: ClinicalPrescribing Information
Facility outpatient hospital163 Date of Service Edit: ClinicalPrescribing Information
DME supplier03 Date of Service Edit: ClinicalCMS Policy

NCCI edits and add-on relationships

No active practitioner PTP pair lists J3301 as a column-1 or column-2 code in v323r0. Drug supply codes are rarely bundled; the administration codes billed with them are where PTP edits usually apply.

J3301 is neither an add-on code nor a designated primary code in the 2026 Q4 NCCI add-on edit file.

Medicare coverage articles

1 current Medicare Administrative Contractor article lists J3301 in their HCPCS tables, covering 3 states. Each article carries the covered and non-covered ICD-10 codes that medical-necessity denials (CARC 50) are adjudicated against.

Billing and Coding Articles listing J3301
ArticleTitleContractor(s)StatesRelated LCD
Billing and Coding: Trigger Point InjectionsFirst Coast Service Options, Inc.FL PR VIL33912

Hospital outpatient (OPPS) status

In the July 2026 OPPS Addendum B, J3301 carries status indicator N. Status N means payment is packaged into the associated procedure and no separate OPPS payment is made.

Common denials for J3301 and how to prevent them

CARC 16 · M119

NDC missing, invalid or not matched to the HCPCS code

CARC 151 · N362

units billed exceed the MUE for the date of service

CARC 50 · N115

diagnosis not covered by the applicable coverage article or LCD

How QuickIntell checks J3301 before the claim leaves

QuickCode validates the NDC-to-unit conversion against the current ASP crosswalk, checks units against every published MUE setting and flags PTP and add-on conflicts on the same claim. QuickRCM routes CARC 16, 151 and 50 denials on drug lines with the matching coverage article attached so the appeal starts with evidence.

Explore QuickCodeExplore QuickRCMBook a demo

Frequently asked questions — HCPCS J3301

What does HCPCS code J3301 describe?

J3301 is defined by CMS as "Injection, triamcinolone acetonide, not otherwise specified, 10 mg". Each billing unit represents 10 MG, so the units reported on the claim must equal the dose administered divided by that unit.

What is the Medicare reimbursement for J3301 in October 2026?

The ASP-based payment limit is $0.787 per 10 MG, with 20% beneficiary coinsurance. Medicare Administrative Contractors apply this limit; commercial payers use their own fee schedules. The July 2026 limit was $0.996.

How many units of J3301 can be billed per day?

The practitioner Medically Unlikely Edit is 16 units per date of service with adjudication indicator 3 (3 Date of Service Edit: Clinical). MAI 3 edits can be appealed with documentation that the units were medically reasonable. CMS cites "Prescribing Information" as the rationale.

Which NDCs map to J3301?

The October 2026 ASP crosswalk lists 41 NDCs from 10 labelers: Kenalog-80 (E.R. Squibb & Sons, L.L.C.); Triamcinolone Acetonide (Hikma Pharmaceuticals USA Inc.); Triamcinolone Acetonide (Teva Parenteral Medicines, Inc.); Triamcinolone Acetonide (Northstar RxLLC). For example NDC 00003-0293-05 is a 1 package equal to 4 billing units. The crosswalk's billing-units-per-package figure converts each package into J3301 units.

Does J3301 have NCCI bundling edits?

No active practitioner PTP pairs list J3301 as a column-1 or column-2 code in the v323r0 release. Unit limits (MUE) and medical-necessity coverage rules still apply.

Which Medicare coverage articles mention J3301?

1 current Billing and Coding Article in the Medicare Coverage Database list J3301, covering 3 states: (Billing and Coding: Trigger Point Injections).

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-01. Verify against the primary file before billing or contracting decisions.

Disclaimer

This page is an operational reference compiled from CMS publications: the Medicare Part B drug payment limit and NDC crosswalk files, NCCI MUE and add-on edit tables, aggregate PTP statistics, OPPS Addendum B and the Medicare Coverage Database. Payment limits are Medicare national amounts; commercial and Medicaid payers differ. CPT codes are shown as numbers only; CPT descriptors are copyright AMA. Nothing here is legal, clinical or billing advice.